ALLTERUM THERAPEUTICS
Allterum Therapeutics is a biopharmaceutical company that develops treatments for relapsed acute lymphoblastic leukemia and other IL-7R expressing cancers. The company is also exploring relapsed/refractory solid tumors with IL-7R over-expression. The 4A10 antibody was developed at the National Cancer Institutes (NCI) and licensed exclusively to Fannin Innovation Studio.
ALLTERUM THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Health Care
Founded:
2018-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.allterum.com
Total Employee:
1+
Status:
Active
Total Funding:
16.7 M USD
Technology used in webpage:
U.S. Server Location Akismet Akismet Non Hosted Accelerated Mobile Pages
Similar Organizations
Century Therapeutics
Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Harmony Biosciences
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Current Employees Featured
Investors List
Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas investment in Grant - Allterum Therapeutics
Fannin Innovation Studio
Fannin Innovation Studio investment in Seed Round - Allterum Therapeutics
Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas investment in Grant - Allterum Therapeutics
Official Site Inspections
http://www.allterum.com
- Host name: 192.0.78.151
- IP address: 192.0.78.151
- Location: San Francisco United States
- Latitude: 37.7506
- Longitude: -122.4121
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94110
More informations about "Allterum Therapeutics"
About Us | Allterum Therapeutics
With an initial focus on hematological malignancies, Allterum Therapeutics is developing 4A10, an anti-CD127 monoclonal antibody for treating acute …See details»
Org Chart Allterum Therapeutics - The Official Board
Organizational Chart of Allterum Therapeutics. Allterum Therapeutics www.allterum.com. +1 713 966 5844See details»
ABOUT ALLTERUM | Allterum Therapeutics
ABOUT ALLTERUM . Developing treatments for CD127 expressing cancers. Contact Us. Email [email protected]. Location 3900 Essex Lane. Ste 575, Houston, Texas 77027 …See details»
Allterum Therapeutics - Crunchbase Company Profile & Funding
Allterum Therapeutics may be growing due to a significant grant acquisition to support clinical evaluation of a cancer-fighting drug. The company has secured a twelve million dollar grant, …See details»
ALLTERUM THERAPEUTICS INC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ALLTERUM THERAPEUTICS INC of Houston, TX. Get the latest business insights from Dun & Bradstreet.See details»
Allterum Therapeutics - LinkedIn
Allterum Therapeutics | 273 followers on LinkedIn. Developing Treatments for ALL. | Allterum Therapeutics is a biopharmaceutical company developing an immunotherapy for pediatric …See details»
Allterum Therapeutics Company Profile 2024: Valuation, Funding ...
Allterum Therapeutics General Information Description. Developer of a monoclonal antibody designed to treat acute lymphoblastic leukemia. The company's antibody can specifically …See details»
Allterum Therapeutics - Products, Competitors, Financials, …
Allterum Therapeutics serves as a biopharmaceutical company focused on developing immunotherapies for oncology, specifically targeting the IL-7 axis. ... (GBI), a contract …See details»
News at Allterum Therapeutics - The Official Board
Allterum Therapeutics has 2,330 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Biogen (United States (USA)). Popular M&A news in Biotechnology Nuvig …See details»
Allterum Therapeutics - Funding, Financials, Valuation & Investors
Allterum Therapeutics is a biopharmaceutical company that develops treatments for different types of cancers. Search Crunchbase. Start Free Trial . Chrome Extension. ... How much …See details»
TEAM | Allterum Therapeutics
Eric Schafer M.D., M.H.S. Assist. Professor Pediatrics-Oncology Baylor College of Medicine & Texas Children’s HospitalSee details»
Allterum Therapeutics - Contacts, Employees, Board Members
Organization. Allterum Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. About. …See details»
Allterum Therapeutics - Overview, News & Similar companies
May 8, 2023 View Allterum Therapeutics (www.allterum.com) location in Texas, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Allterum - Company Profile - Tracxn
Nov 5, 2024 Allterum ranks 43rd among 311 active competitors. 122 of its competitors are funded while 76 have exited. Overall, Allterum and its competitors have raised over $14B in …See details»
OUR PARTNERS & COLLABORATORS - Allterum
Sarah’s lab is collaborating with Allterum to evaluate 4A10 in PDX models of B-ALL. ... Los Angeles, CA Allterum will work with TACL to design, run, and manage its Phase I clinical trial. …See details»
Allterum - Raised $65.8M Funding from 7 investors - Tracxn
Nov 5, 2024 List of Allterum's institutional investors. Orbimed, located in New York City (United States), made their first investment in Allterum on Jan 20, 2022 in its Series A round.; Nextech …See details»
GBI Biomanufacturing and Allterum Therapeutics Announce …
Oct 7, 2024 PLANTATION, Florida and HOUSTON, Texas, Oct. 7, 2024 /PRNewswire/ -- GBI Biomanufacturing, a leading Contract Development and Manufacturing Organization (CDMO), …See details»
Houston startup scores $12M grant to support clinical evaluation …
Apr 2, 2024 Allterum Therapeutics, a Houston biopharmaceutical company, has been awarded a $12 million product development grant from the Cancer Prevention and Research Institute of …See details»
OUR SCIENCE & RESEARCH - Allterum
Allterum is building a franchise addressing the CD127 pathway starting with 4A10, a monoclonal antibody targeted against CD127. CD127 is part of a receptor complex located on T-cells and …See details»